3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Recurrence
1
Neoplasms, Plasma Cell
1
Mesothelioma, Malignant
1
Carcinoma, Non-Small-Cell Lung
1
Advanced or Metastatic Solid Tumors
1
Advanced Breast Cancer
1
Interventions
pembrolizumab
3
envafolimab
3
Nivolumab
2
trifluridine tipiracil drug combination
1
tebentafusp
1
surufatinib
1
sintilimab
1
linifanib
1
Injections
1
Drug Therapy
1
Doxorubicin
1
Combined Modality Therapy
1
Bortezomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Advanced or Metastatic Solid Tumors
×
Combined Modality Therapy
×
Clear all
NCT05957081
2025-12-30
MarkV-01
PharmAbcine
Phase 1
Recruiting
67 enrolled